Swine Healthcare Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 3.30 Billion |
| Market Size (2029) | USD 4.54 Billion |
| CAGR (2024 - 2029) | 6.59 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Swine Healthcare Market Analysis
The Swine Healthcare Market size is estimated at USD 3.30 billion in 2024, and is expected to reach USD 4.54 billion by 2029, growing at a CAGR of 6.59% during the forecast period (2024-2029).
The COVID-19 pandemic led to disruptions in not only the R&D activities of other therapies and drugs for medical conditions other than COVID-19 but also impacted the veterinary industry, as the logistics supply of various essential veterinary pharmaceutical products was adversely impacted. For instance, according to the research study published by Anna K. Johnson in the December 2021 issue of the National Library of Medicine, due to the COVID-19 pandemic, supply chain disruptions in Lowa, United States, caused producer uncertainty, confusion, and stress, including time-sensitive challenges for maintaining animal care. To overcome these challenges, the Lowa Resource Coordination Center (IRCC) was created to support swine welfare. Therefore, COVID-19 had an unprecedented impact on the swine healthcare market in its initial phase; however, with the slowing down of infections and large-scale vaccinations, the studied market is expected to reach the potential of the pre-COVID era. For instance, in January 2022, an article published by William Reed stated that pig feed production in 2021 increased by 6.5% due to growth in the Asia-Pacific region. Thus, with such increased growth, the market is expected to grow over the forecast period.
The major factor driving the growth of the swine healthcare market is the rising incidence of swine diseases around the world, which is expected to drive the demand for swine healthcare products for diagnostics and treatment. For instance, according to the March 2022 update of the FAO of the United Nations, African swine fever (ASF) has been reported in the administrative areas of the following countries, namely, China, Mongolia, Vietnam, Cambodia, the Democratic People's Republic of Korea, Myanmar, the Philippines, Indonesia, India, Malaysia, and others, which shows a high prevalence of ASF in different countries of the world. Thus, the demand for diagnostics and treatment products for ASF is expected to increase, which is expected to fuel the growth of the studied market.
As per the research study published in September 2021 by Yin Li and Ian Robertson, swine influenza is a major health concern for the swine industry, as swine influenza can not only cause large economic losses for the pig industry but can also lead to epidemics or pandemics in the human population, and it is one of the most ubiquitous diseases circulating in the global pig population. As per the same source, the major diagnostic techniques used for detecting swine influenza include serological methods (e.g., hemagglutination inhibition (HI) test and enzyme-linked immunosorbent assay (ELISA)), molecular methods (e.g., polymerase chain reaction (PCR)), and virus isolation methods. Hence, with the growing burden of these diseases and awareness about them, the demand for swine healthcare products is anticipated to increase over the forecast period.
Moreover, the increasing demand for livestock products, along with increasing R&D investment in the area of novel therapeutics, is expected to augment the growth of the swine healthcare market. For instance, in September 2021, the United States Department of Agriculture pledged up to USD 500 million from the Commodity Credit Corporation to prevent African swine fever. The amount will be spent on expansion, coordination, monitoring, and surveillance of the disease, along with other efforts. However, the stringent regulatory policies and high cost of swine healthcare products are expected to impede the growth of the swine healthcare market during the forecast period.
Swine Healthcare Market Trends
Vaccines in the Therapeutics Segment is Expected to Hold a Major Share in the Studied Market
Vaccines consist of attenuated or killed microbes or microbial DNA, and upon administration, the immune system triggers a response that produces antibodies, thus increasing immunity. New advanced vaccines have been manufactured that contain genetically engineered components derived from disease-causing agents. They are given to pigs, usually by injection, to stimulate an immune response that will protect the pigs against later natural infection with the organism from which the vaccine was derived. Vaccines impart immunity to the pigs in the most efficient way and are highly effective. Hence, the vaccine segment is expected to grow significantly over the forecast period.
Owing to the high efficiency and effectiveness of the vaccines for swine health, key companies, as well as academic research institutes, are investing heavily in the area of the development, approval, and launch of new vaccines, which is expected to fuel the growth in the studied market as a new product in the market will increase the competition in the studied market. For instance, in May 2022, Boehringer Ingelheim, a global leader in animal health, launched TwistPak, a revolutionary mixing platform. It enables swine producers to combine two vaccines, Ingelvac CircoFLEX and Ingelvac MycoFLEX, in a convenient, fast, and flexible way. The positive outcome from the undergoing vaccine candidates is further expected to have a positive impact on the growth of the studied segment. For instance, as per the September 2021 report of the United States Department of Agriculture (USDA), one of its African Swine Fever Virus (ASFV) vaccine candidates has been shown to prevent and effectively protect both European and Asian-bred swine against the current circulating Asian strain of the virus. Therefore, with the high efficiency of vaccines against swine diseases, new launches, and research studies, the vaccine segment is expected to hold a major share of the studied market over the forecast period.
North America is Expected to Dominate the Swine Healthcare Market Over the Forecast Period
North America is expected to dominate the market due to the presence of a well-established swine industry and the rising incidence of swine infections, such as Swine Enteric Coronavirus Disease (SECD), Porcine Epidemic Diarrhea (PEDv), and Porcine Delta Coronavirus (PDCoV), which cause significant morbidity and mortality, particularly in young piglets. All these factors are collectively driving the growth of the studied market in the region.
In the North American region, the United States is expected to occupy a major market share in the swine healthcare market. Investment in the country is expected to increase market growth over the forecast period. For instance, in March 2022, the United States Department of Agriculture awarded USD 642,000 to Cornell University for the development of more effective swine influenza vaccines. Such grants are expected to increase market growth over the forecast period as they will increase the research and development activities resulting in the development of innovative vaccines.
Furthermore, the approval of new drugs or vaccines is expected to increase market growth in the region. For instance, in April 2022, scientists with the US Department of Agriculture's Agricultural Research Service (ARS) stated that a vaccine candidate for African Swine Fever (ASF) passed an important safety test required for regulatory approval, moving the vaccine one step closer to commercial availability. Thus, with initiatives such as increasing grants and approvals, the market is expected to grow over the forecast period.
Swine Healthcare Industry Overview
The market players in the swine health market are involved in various growth strategies such as collaborations, partnerships, agreements, mergers, and acquisitions, along with product development and launch, to enhance their market presence. The swine healthcare market is moderately competitive. Some of the major market players in the studied market include Zoetis Animal Healthcare, Merck Animal Health, IDVet, Elanco, and Ceva Animal Health Inc.
Swine Healthcare Market Leaders
-
Merck Animal Health
-
IDVet
-
Elanco
-
Ceva Animal Health Inc.
-
Zoetis Animal Healthcare
*Disclaimer: Major Players sorted in no particular order
Swine Healthcare Market News
- June 2022: AVAC Vietnam Company Limited launched its campaign against African swine fever. Its safety and efficacy were confirmed by the Agricultural Research Service under the US Department of Agriculture.
- March 2022: assistant professor, Mohit Verma of Purdue University, received funding of USD 1 million for the research and development of an African swine fever rapid test from the National Animal Health Laboratory Network and the National Animal Disease Preparedness and Response Program.
Swine Healthcare Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Incidence of Swine Diseases
- 4.2.2 Increasing Demand for Livestock Products
- 4.2.3 Increasing Investments in R&D Activities to Develop Novel Therapeutics
-
4.3 Market Restraints
- 4.3.1 Stringent Regulatory Framework
- 4.3.2 High Cost Associated with Swine Health Especially in the Developing Countries
-
4.4 Porter Five Forces
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Product
- 5.1.1 Diagnostic Tests
- 5.1.1.1 Enzyme Linked Immuno-Sorbent Assay (ELISA)
- 5.1.1.2 Rapid Immuno Migration (RIM)
- 5.1.1.3 Agar Gel Immuno-Diffusion (AGID)
- 5.1.1.4 Polymerase Chain Reaction (PCR)
- 5.1.1.5 Diagnostic Imaging
- 5.1.1.6 Other Diagnostics
- 5.1.2 Therapeutics
- 5.1.2.1 Vaccines
- 5.1.2.2 Parasiticides
- 5.1.2.3 Anti-infectives
- 5.1.2.4 Feed additives
- 5.1.2.5 Other Therapeutics
-
5.2 By Disease
- 5.2.1 Exudative dermatitis (greasy pig disease)
- 5.2.2 Coccidiosis
- 5.2.3 Respiratory diseases
- 5.2.4 Swine dysentery
- 5.2.5 Porcine parvovirus
- 5.2.6 Other Diseases
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Boehringer Ingelheim GmbH
- 6.1.2 Ceva Animal Health Inc.
- 6.1.3 Elanco
- 6.1.4 IDVet
- 6.1.5 Merck & Co. Inc.
- 6.1.6 Vetoquinol SA
- 6.1.7 Virbac
- 6.1.8 Zoetis Animal Healthcare
- 6.1.9 IDEXX Laboratories Inc.
- 6.1.10 Phibro Animal Health
- 6.1.11 Huvepharma
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablitySwine Healthcare Industry Segmentation
As per the scope of the report, pig production is an important component of global food security, agricultural economies, and local and international trade, and swine health is associated with various diseases associated with pigs. The development of diagnostics and therapeutics products to prevent related ailments and disorders affects the stability and productivity of the global swine industry. The Swine Healthcare Market is Segmented by Products (Diagnostics Tests (Enzyme-Linked Immuno-Sorbent Assay (ELISA), Rapid Immuno Migration (RIM), Agar Gel Immuno-Diffusion (AGID), Polymerase Chain Reaction (PCR), Diagnostic Imaging, and Other Diagnostics) and Therapeutics (Vaccines, Parasiticides, Anti-infectives, Feed additives, and Other Therapeutics), Disease (Exudative Dermatitis, Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, and Other Diseases), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD million) for the above segments.
| By Product | Diagnostic Tests | Enzyme Linked Immuno-Sorbent Assay (ELISA) |
| Rapid Immuno Migration (RIM) | ||
| Agar Gel Immuno-Diffusion (AGID) | ||
| Polymerase Chain Reaction (PCR) | ||
| Diagnostic Imaging | ||
| Other Diagnostics | ||
| By Product | Therapeutics | Vaccines |
| Parasiticides | ||
| Anti-infectives | ||
| Feed additives | ||
| Other Therapeutics | ||
| By Disease | Exudative dermatitis (greasy pig disease) | |
| Coccidiosis | ||
| Respiratory diseases | ||
| Swine dysentery | ||
| Porcine parvovirus | ||
| Other Diseases | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Swine Healthcare Market Research FAQs
How big is the Swine Healthcare Market?
The Swine Healthcare Market size is expected to reach USD 3.30 billion in 2024 and grow at a CAGR of 6.59% to reach USD 4.54 billion by 2029.
What is the current Swine Healthcare Market size?
In 2024, the Swine Healthcare Market size is expected to reach USD 3.30 billion.
Who are the key players in Swine Healthcare Market?
Merck Animal Health, IDVet, Elanco, Ceva Animal Health Inc. and Zoetis Animal Healthcare are the major companies operating in the Swine Healthcare Market.
Which is the fastest growing region in Swine Healthcare Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Swine Healthcare Market?
In 2024, the North America accounts for the largest market share in Swine Healthcare Market.
What years does this Swine Healthcare Market cover, and what was the market size in 2023?
In 2023, the Swine Healthcare Market size was estimated at USD 3.08 billion. The report covers the Swine Healthcare Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Swine Healthcare Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Swine Healthcare Industry Report
Statistics for the 2024 Swine Healthcare market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Swine Healthcare analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
